In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Elena Arbelo
Elena Arbelo Elena Arbelo

Hospital Clinic, Universitat de Barcelona, Barcelona (Spain)

Specialities : Arrhythmias-General , Atrial Fibrillation, Ventricular Arrhythmias and Sudden Cardiac Death (SCD), Public Health and Health Economics, Pregnancy and Cardiovascular Disease

Cardiac Electrophysiologist at Hospital Clínic of Barcelona. Coordinator of the Cardiac Genetic Diseases and Sudden Arrhythmic Death Unit. Cardiovascular Institute Coordinator for Quality and Safety. Clinical professor of the Universitat de Barcelona and recognised researcher of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Member of several Committees of the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS, United States). Committee member for several large scale European Registries to gather data on atrial fibrillation and guideline implementation in these registries. Member of the Working Group on Atrial Fibrillation of the International Consortium for Health Outcomes Measurement (ICHOM). Part of the RightCare and LEAN management task forces in Hospital Clinic.

19 presentations from this speaker

2020 ESC Guidelines on Atrial Fibrillation - Live.

Event : ESC Congress 2020

  • Session : 2020 ESC Guidelines on Atrial Fibrillation - Live
  • Speaker : G Hindricks (Leipzig,DE), IC Van Gelder (Groningen,NL), G Boriani (Castenaso-Bo,IT), GYH Lip (Liverpool,GB), C Blomstrom-Lundqvist (Uppsala,SE), E Arbelo (Barcelona,ES), TS Potpara (Belgrade,RS)

New ways to treat atrial fibrillation – What to choose and in whom?

Event : ESC Congress 2020

  • Session : Tachyarrhythmia and Atrial Fibrillation - Essential Update
  • Speaker : E Arbelo (Barcelona,ES)

Quality of AF management: outcome measures and patient reported outcomes.

Event : ESC Congress 2020

  • Session : 2020 ESC Guidelines on Atrial Fibrillation
  • Speaker : E Arbelo (Barcelona,ES)

Case 3: when is enough enough? Postablation atrial fibrillation recurrences.

Event : ESC Congress 2019

  • Session : Meet the Experts - Pushing the boundaries. Are there any limits for atrial fibrillation ablation indications?
  • Speaker : E Arbelo (Barcelona,ES)

ESC Guidelines on supraventricular tachycardias. What is new?

Event : ESC Congress 2019

  • Session : Meet the Task Force of the 2019 ESC Guidelines on Supraventricular Tachycardias
  • Speaker : E Arbelo (Barcelona,ES)

Male 50 years persistent atrial fibrillation no symptoms

Event : EHRA 2019

  • Session : Case-based optimal therapy of atrial fibrillation
  • Speaker : E Arbelo (Barcelona,ES)

Supraventricular tachycardia (non-AF) - Epidemiology, prognosis, outcome

Event : ESC Congress 2019

  • Session : 2019 ESC Guidelines on Supraventricular Tachycardias
  • Speaker : E Arbelo (Barcelona,ES)

Automatic Brugada pattern detection on continuous electrocardiographic monitoring

Event : EHRA 2017

  • Session : ECG and eCardiology
  • Speaker : E Arbelo (Barcelona,ES)

Clinical, electrocardiographic, imaging and mapping data to discriminate right from left PVC origin

Event : ESC Congress 2017

  • Session : High burden of ventricular ectopic beats: what have we learned in the last decades?
  • Speaker : E Arbelo (Barcelona,ES)

Genetic risk prediction of atrial fibrillation.

Event : EHRA 2017

  • Session : New strategies for prediction, prevention and treatment of atrial fibrillation
  • Speaker : E Arbelo (Barcelona,ES)
  • Joint Session with the Asia Pacific Heart Rhythm Society (APHRS)

Long-term prognosis of Brugada syndrome patients with syncope

Event : EHRA 2017

  • Session : Moderated Poster session 3 - Arrhytmias in congenital heart disease and inherited disorders
  • Speaker : E Arbelo (Barcelona,ES)

Long-term prognosis of Brugada syndrome patients with syncope

Event : ESC Congress 2017

  • Session : Ventricular arrhythmias: Improved treatment and risk prediction
  • Speaker : E Arbelo (Barcelona,ES)

Solid PVI only is still enough.

Event : EHRA 2017

  • Session : The best strategy for ablation of persistent atrial fibrillation: who makes the race?
  • Speaker : E Arbelo (Barcelona,ES)

Risk of arrhythmias and sudden cardiac death

Event : ESC Congress 2016

  • Session : Sport is not always healthy for your heart – A double-edged sword
  • Speaker : E Arbelo (Barcelona,ES)

Antiarrhythmic drugs in catheter ablation patients – current practice in Europe.

Event : EHRA 2015

  • Session : Combining antiarrhythmic drugs and catheter ablation in persistent AF in Europe and Japan – Emerging concepts for improved rhythm control
  • Speaker : E Arbelo (Barcelona,ES)

Brugada syndrome: time-trend in incidence and prognosis

Event : ESC Congress 2015

  • Session : Mechanisms of arrhythmias and channelopathies
  • Speaker : E Arbelo (Barcelona,ES)

Cardiac arrhythmias.

Event : ESC Congress 2015

  • Session : Cardio-oncology
  • Speaker : E Arbelo (Barcelona,ES)
  • ESC and the InterAmerican Society of Cardiology

Atrial fibrillation as a marker of clinical severity in brugada syndrome.

Event : ESC Congress 2013

  • Session : Genetic aspects of arrhythmias
  • Speaker : E Arbelo (Barcelona,ES)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are